Corporate lobbying spender PFE saw a rise of 5% in stock price yesterday

Quiver Quantitative

@QuiverQuant

·Follow

Pfizer saw a nearly 7% surge in stock price today and was also one of the top spenders on corporate lobbying in the last month. Over the past year, their lobbying expenditure hit almost $19M, while they secured $16B in government contracts. Not a bad return.